5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.14▼ | 5.14▼ | 5.16▼ | 5.53▼ | 5.48▼ |
MA10 | 5.14▼ | 5.19▼ | 5.25▼ | 5.62▼ | 5.20▼ |
MA20 | 5.12▲ | 5.27▼ | 5.38▼ | 5.62▼ | 6.66▼ |
MA50 | 5.17▼ | 5.52▼ | 5.65▼ | 5.18▼ | 6.46▼ |
MA100 | 5.27▼ | 5.66▼ | 5.67▼ | 6.63▼ | 4.66▲ |
MA200 | 5.43▼ | 5.65▼ | 5.43▼ | 6.51▼ | 4.41▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.006▲ | -0.002▼ | -0.019▼ | -0.049▼ | -0.135▼ |
RSI | 45.965▼ | 27.302▼ | 27.133▼ | 42.839▼ | 44.189▼ |
STOCH | 62.667 | 21.398 | 16.630▼ | 36.145 | 41.361 |
WILL %R | -23.077▲ | -71.429 | -80.769▼ | -92.057▼ | -81.781▼ |
CCI | -1.709 | -91.631 | -114.280▼ | -171.302▼ | -24.484 |
Friday, June 06, 2025 05:12 AM
NEEDHAM, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal ...
|
Monday, June 02, 2025 06:55 AM
Shares of Candel Therapeutics, Inc. (CADL) have gained 3.2% over the past four weeks to close the last trading session at $5.45, but there could still be a solid upside left in the stock if short ...
|
Thursday, May 29, 2025 08:41 PM
Candel Therapeutics, Inc. (NASDAQ:CADL) has secured FDA Regenerative Medicine Advanced Therapy (RMAT) designation for its lead immunotherapy candidate, CAN-2409 (aglatimagene besadenovec), targeting ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 5.28 | 5.4354 | 5.03 | 5.13 | 726,654 |
12/06/25 | 5.40 | 5.5799 | 5.26 | 5.36 | 684,784 |
11/06/25 | 5.85 | 5.90 | 5.44 | 5.46 | 828,505 |
10/06/25 | 5.945 | 6.11 | 5.815 | 5.86 | 461,446 |
09/06/25 | 6.16 | 6.169 | 5.775 | 5.86 | 710,974 |
06/06/25 | 5.56 | 6.1961 | 5.56 | 6.04 | 1,144,758 |
05/06/25 | 5.62 | 5.64 | 5.41 | 5.55 | 1,090,084 |
04/06/25 | 5.78 | 5.98 | 5.55 | 5.60 | 880,920 |
03/06/25 | 5.68 | 6.017 | 5.4905 | 5.75 | 995,022 |
02/06/25 | 5.46 | 5.70 | 5.365 | 5.59 | 616,544 |
|
|
||||
|
|
||||
|
|